Abstract
In this review dealing with the rationale for combination chemotherapy of brain tumours, two main issues will be considered: (a) what are the characteristics of brain tumours most likely to determine the choice of chemotherapeutic drugs, and (b) is there any clinical evidence supporting the view that combination chemotherapy is superior to single-drug therapy in human brain neoplasms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blasberg, R., Patlack, C., Shapiro, W., Fenstermacher, J.: Metastatic brain tumours: local blood flow and capillary permeability. Neurology 29, 547, 1979
EORTC brain tumour group: Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma: final evaluation. Europ. J. Cancer 14, 851–856, 1978
EORTC brain tumour group: Evaluation of the CCNU, VM26 plus CCNU and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J. Neurosurg. 55, 27–31, 1981
Fewer, D., Wilson, C. B., Boldrey, E. B., Enot, K. J., Powell, M. R.: The chemotherapy of brain tumours: clinical experience in the carmustine (BCNU) and vincristine. JAMA 222, 544–559, 1972
Hildebrand, J., Nouwynck, C.: Malignant gliomas. In: Randomized trials in cancer, a critical review by sites. M. J. Staquet (ed.), pp. 377–388. New York: Raven Press 1978
Hoshino, T., Barker, M., Wilson, C. B.: The kinetics of cultured human glioma cells. Acta Neuropathol. 32, 235–244, 1975
Levin, V. A., Patlack, C. S., Landahl, H. D.: Heuristic modelling of drug delivery to malignant brain tumour. J. Pharmacokinet. Biopharm. 8, 257–296 (1980)
Long, J. M.: Capillary ultrastructure and blood-brain barrier in human brain tumours. J. Neurosurg. 32, 127–144, 1970
Neuwelt, E. A., Diehl, J. T., Long, H. W., Hill, R. N., Michael, A. J., Frenkel, E. P.: Monitoring of methotrexate delivery in patients with malignant brain tumours after osmotic blood-brain barrier disruption. Ann. Intern. Med. 94, 449–454, 1981
Norell, H., Wilson, C. B., Slagel, D. E., Clark, D. B.: Leukoencephalopathy following the administration of methotrexate in the cerebrospinal fluid in treatment of primary brain tumours. Cancer 33, 923–932, 1974
Shapiro, W. R., Chernik, N. L., Posner, J. B.: Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch. Neurol. 28, 96–102, 1973
Shapiro, J. R., Yung, A., Wei-Kwan, Shapiro, W. R.: Isolation, karyotype and clonal growth of heterogeneous subpopulation of human malignant gliomas. Cancer Res. 41, 2349–2359, 1981
van Putten, L. M., Keizer, H. J., Mulder, J. H.: Syndromization in tumour chemotherapy. Europ. J. Cancer 12, 79–85, 1976
Wilson, C. B., Gutin, P., Boldrey, E. B., Crafts, D., Levin, V. A., Enot, J.: Single agent chemotherapy of brain tumours. Arch. Neurol. 33, 739–144, 1976
Wilson, C. B., Yorke, C. H. Jr., Levin, V. A.: Intracranial malignant growth, primary and metastatic. In: Current problems in cancer. R. C. Hickey (ed.), Year Book Medical Publishers, Vol. I, Nr. 8, 1977
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hildebrand, J., de Beyl, D.Z. (1982). Rationale of Combined Chemotherapy of Brain Tumours. In: Voth, D., Gutjahr, P., Langmaid, C. (eds) Tumours of the Central Nervous System in Infancy and Childhood. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95413-9_55
Download citation
DOI: https://doi.org/10.1007/978-3-642-95413-9_55
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-95415-3
Online ISBN: 978-3-642-95413-9
eBook Packages: Springer Book Archive